Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction
-
- Jawad H. Butt
- Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
-
- Kieran F. Docherty
- BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
-
- Mark C. Petrie
- BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
-
- Morten Schou
- Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark
-
- Mikhail N. Kosiborod
- St Luke’s Mid America Heart Institute, University of Missouri–Kansas City
-
- Eileen O’Meara
- Department of Cardiology, Montreal Heart Institute, Montreal, Ontario, Canada
-
- Tzvetana Katova
- Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria
-
- Charlotta E. A. Ljungman
- Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy, Gothenburg, Sweden
-
- Mirta Diez
- Division of Cardiology, Institute Cardiovascular de Buenos Aires, Buenos Aires, Argentina
-
- Modele O. Ogunniyi
- Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
-
- Anna Maria Langkilde
- Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
-
- Mikaela Sjöstrand
- Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
-
- Daniel Lindholm
- Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
-
- Olof Bengtsson
- Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
-
- Felipe A. Martinez
- Universidad Nacional de Córdoba, Córdoba, Argentina
-
- Piotr Ponikowski
- Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wrocław, Poland
-
- Marc S. Sabatine
- TIMI Study Group, Brigham and Women’s Hospital, Boston, Massachusetts
-
- Scott D. Solomon
- Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
-
- Pardeep S. Jhund
- BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
-
- John J. V. McMurray
- BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
-
- Lars Køber
- Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
書誌事項
- タイトル別名
-
- A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial
収録刊行物
-
- JAMA Cardiology
-
JAMA Cardiology 6 (6), 678-, 2021-06-01
American Medical Association (AMA)
